businesses, market acceptance,
government regulation and regulatory approval processes, intellectual
property rights and litigation, dependence on collaborative relationships,
ability to obtain financing, competitive products, industry trends and
other risks identified in deCODE's filings with the Securities and Exchange
Commission. deCODE undertakes no obligation to update or alter these
forward-looking statements as a result of new information, future events or
otherwise.
Contacts:
deCODE genetics
Berglind Olafsdottir
+354 570 2393
info@decode.is
'/>"/>SOURCE deCODE genetics, Inc. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Wisconsin court affirms damages in Innogenetics, Abbott patent case2.
Third Wave licenses Innogenetics tech to settle lawsuit3.
Symposium examines the effect of race on genetics and disease4.
Speaker announces business members of IT Task Force5.
Doyle announces technology tax credits for Berbee6.
Doyle announces new energy, global warming policies7.
Doyle announces $80M renewable energy strategy8.
GE announces first installation of Discovery VCT9.
UWM announces winners of RGI awards10.
Third Wave announces two senior management appointments11.
Mirus announces new method for making antibodies